Clinical and translational studies of a phase II trial of the novel oral Akt inhibitor perifosine in relapsed or relapsed/refractory Waldenström's macroglobulinemia

Irene M. Ghobrial, Aldo Roccaro, Fangxin Hong, Edie Weller, Nancy Rubin, Renee Leduc, Meghan Rourke, Stacey Chuma, Antonio Sacco, Xiaoying Jia, Feda Azab, Abdel Kareem Azab, Scott Rodig, Diane Warren, Brianna Harris, Lyuba Varticovski, Peter Sportelli, Xavier Leleu, Kenneth C. Anderson, Paul G. Richardson

Research output: Contribution to journalArticlepeer-review

100 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical and translational studies of a phase II trial of the novel oral Akt inhibitor perifosine in relapsed or relapsed/refractory Waldenström's macroglobulinemia'. Together they form a unique fingerprint.

Medicine & Life Sciences